Your browser doesn't support javascript.
loading
Antisense Oligonucleotide-Induced Amyloid Precursor Protein Splicing Modulation as a Therapeutic Approach for Dutch-Type Cerebral Amyloid Angiopathy.
Daoutsali, Elena; Hailu, Tsinatkeab T; Buijsen, Ronald A M; Pepers, Barry A; van der Graaf, Linda M; Verbeek, Marcel M; Curtis, Daniel; de Vlaam, Thomas; van Roon-Mom, Willeke M C.
Afiliação
  • Daoutsali E; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Hailu TT; Amylon Therapeutics, Leiden, the Netherlands.
  • Buijsen RAM; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Pepers BA; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • van der Graaf LM; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Verbeek MM; Departments of Neurology and Laboratory Medicine, Radboud Alzheimer Centre, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
  • Curtis D; Amylon Therapeutics, Leiden, the Netherlands.
  • de Vlaam T; Atalanta Therapeutics, Boston, Massachusetts, USA.
  • van Roon-Mom WMC; Amylon Therapeutics, Leiden, the Netherlands.
Nucleic Acid Ther ; 31(5): 351-363, 2021 10.
Article em En | MEDLINE | ID: mdl-34061681
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopatia Amiloide Cerebral / Precursor de Proteína beta-Amiloide Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopatia Amiloide Cerebral / Precursor de Proteína beta-Amiloide Idioma: En Ano de publicação: 2021 Tipo de documento: Article